Matrix Pharmaceutical

Mecox Curemed

This pharmaceutical company develops drug delivery systems and oncology treatments for healthcare providers and patients through platform-based drug development.

Cell Pathways

This pharmaceutical company develops medicines to treat and prevent precancerous lesions and cancer for patients in the oncology and dental markets.

Spherics

This pharmaceutical company develops oral drug delivery technologies to create improved therapeutic products for patients with central nervous system disorders and other medical conditions.

UroGen Pharma

This company develops and commercialises hydrogel-based medicines for patients with urological and specialty cancers, including treatments for low-grade upper tract urothelial carcinoma and bladder cancer.

Convert Pharmaceuticals

The company develops hypoxia-activated prodrugs that transform into anti-cancer agents to treat patients with solid tumours.

Avistone Pharmaceuticals

The company develops and manufactures precision oncology medicines, specifically small-molecule targeted therapies for patients with lung cancer and other solid tumours.

Combat Medical

This company manufactures hyperthermic drug delivery systems for hospitals and oncology clinics to treat patients with bladder and peritoneal cancers.

Gloucester Pharmaceuticals

This company develops oncology drug candidates, including romidepsin, for the treatment of patients with cutaneous and peripheral T-cell lymphoma.